Form 4: Teva Pharmaceutical Industries Executive Vikki L. Conway Sells Shares
SEC Form 4 Filing
Vikki L. Conway, Acting Head of Global Human Resources at Teva Pharmaceutical Industries, sold 15,219 ordinary shares at an average price of $16.7427 on May 13, 2024.
Summary
- On May 13, 2024, Vikki L. Conway, Acting Head of Global Human Resources at Teva Pharmaceutical Industries, sold 15,219 ordinary shares of the company.
- The shares were sold at a weighted average price of $16.7427.
- The sales occurred in multiple transactions with prices ranging from $16.74 to $16.76.
- This transaction was reported on a Form 4 filing with the SEC.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of a share sale by an executive. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
This is a routine disclosure of an insider transaction. It's common for executives to periodically sell shares for personal financial management.
Stakeholder Impact
- The sale of shares by an executive could be perceived negatively by some shareholders, but it's a relatively small transaction and unlikely to have a significant impact.
Key Dates
| Date | Description |
|---|---|
| 05/13/2024 | Date of the transaction: Vikki L. Conway sold 15,219 ordinary shares. |
| 05/15/2024 | Date of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.